Home Tags Chemicals
Microcap investor Shore Capital Partners has agreed to sell eye care management services business EyeSouth to fellow private equity investor Olympus Partners.
The $34.5bn-managing Pennsylvania State Employees’ Retirement System has picked Ardian's latest secondaries megafund for its latest alternatives investment.
UK private equity house ICG has seen its €4.2bn buyout offer for the Evidian unit of beleagured French tech consultancy Atos unit rejected.
Fort Point Capital, the lower mid-market buyout house set up by a pair of former Fidelity Equity Partners execs, has hit a $340m hard cap final close for its third fund - just over 18 months after closing its predecessor vehicle.
Goldman Sachs is back in the market with the successor to its $2.75bn real estate secondaries fund from 2020 - the latest in a string of big alternatives capital raises from the investment giant.
Ex-NFL star quarterback Eli Manning has scored his first private equity deal as part of Brand Velocity Group with the acquisition of youth team uniforms and equipment provider Score Sports.
The C$242bn-managing Ontario Teachers’ Pension Plan has launched its first Indian office after idenitifying the country as one of its key growth markets.
Cloud-based compliance and reporting platform Workiva has reportedly picked up buyout interest from private equity heavyweights TPG and Thoma Bravo.
Automated payments specialist Billtrust is set to return to private equity ownership, less than two years after becoming a Nasdaq-listed company through a SPAC merger.
London-based Apposite Capital has hit a £200m final close for its latest fund targeting high growth and high impact healthcare and life science SMEs across Europe.